CAROLINA NÖR
![](http://www.evecon.com.br/bandeiras/eua.gif)
Graduated in Pharmacy from UFRGS (2004) with qualifications in industrial pharmacy (2006) and master's degree in Pharmaceutical Sciences from UFRGS (2006). She worked in the pharmaceutical industry as a researcher developing new products at the company Cristália Produtos Químicos Farmacêuticos LTDA (2006 - 2008). Has experience in implementing and conducting drug stability studies. He holds a doctorate from the Postgraduate Program in Cellular and Molecular Biology at UFRGS (2013), with a sandwich internship at the University of Michigan (2011-2012). He has experience in the search for molecules with antitumor activity, based on in vitro studies, cellular and molecular biology, and in vivo, manipulation of immunocompromised animals.
Confira a agenda de atividades
23 DE MARÇO | SÁBADO
Room 3
13:30-15:30
SESSION 4: PRESENT - FUTURE
Is proton beam therapy a real deal in pediatric neurooncology?
Pre-clinical studies in medulloblastoma: what is new?
Genetic Predisposition Syndromes: How new molecular technologies can help us in the diagnosis and treatment
When does Precision Medicine make a difference in the treatment of our pediatric patients with brain tumors?
The Medulloblastoma initiative-
Liquid biopsy for pediatric neurooncology tumors. Is it possible?
Study Protocol and Perspectives: Embryonal Tumors in infants
Discussion
Moderator: Gabriela Bellas (RJ)
Moderator: Maria Luisa Sucharski Figueiredo (Brasil)
Is proton beam therapy a real deal in pediatric neurooncology?
Speaker: Michael Jenwei Chen (SP)
Pre-clinical studies in medulloblastoma: what is new?
Speaker: Carolina Nör (Estados Unidos)
Genetic Predisposition Syndromes: How new molecular technologies can help us in the diagnosis and treatment
Speaker: Fernanda Teresa de Lima (SP)
When does Precision Medicine make a difference in the treatment of our pediatric patients with brain tumors?
Speaker: Elvis Terci Valera (SP)
The Medulloblastoma initiative-
Speaker: Fernando Goldsztein (RS)
Liquid biopsy for pediatric neurooncology tumors. Is it possible?
Speaker: Liana Figueiredo Nobre (Canadá)
Study Protocol and Perspectives: Embryonal Tumors in infants
Speaker: Natália Dassi (SP)
Discussion